
Sign up to save your podcasts
Or


Editor’s Choice: A phase II, randomized, double-blind study of the use of rucaparib vs. placebo maintenance therapy in metastatic and recurrent endometrial cancer
By Gynecologic Oncology5
1818 ratings
Editor’s Choice: A phase II, randomized, double-blind study of the use of rucaparib vs. placebo maintenance therapy in metastatic and recurrent endometrial cancer

25,830 Listeners

87,458 Listeners

112,501 Listeners

56,536 Listeners

34 Listeners

1,808 Listeners

10,523 Listeners